PubRank

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

Clinical Trial ID NCT00413725

PubWeight™ 16.30‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00413725

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002 12.49
2 Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis 2011 3.71
3 Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 2004 3.52
4 Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis 2014 1.86
5 Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol 2008 1.71
6 Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009 1.69
7 Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect 2010 1.60
8 Uptake of male circumcision in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2009 1.10
9 Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol 2012 0.92
10 Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women. PLoS One 2012 0.86
11 Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men. PLoS One 2015 0.82
12 The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Int J STD AIDS 2013 0.79
13 Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses. PLoS One 2014 0.77
14 Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02. J Infect Dis 2016 0.75
Next 100